MedPath

Parent-child interaction therapy for aggression in children of caregiver with cancer, a double-blind randomized controlled trial

Phase 1
Completed
Conditions
All stages of the research were performed after obtaining informed written consent from the parents and the verbal consent of the child and based on the latest version of Helsinki Declaration.
Parent&#45
Child interaction therapy&#44
Aggression&#44
Tetrahydrocannabinol&#44
Addiction&#44
Cancer
Registration Number
TCTR20190121001
Lead Sponsor
none
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
50
Inclusion Criteria

The inclusion criteria were: 1) age range of 5-7 years in children; 2) the diagnosis of metastatic cancer stage 4 in at least one parent or caregiver; 3) the diagnosis of dependence to cannabis with a given dose by caregiver; 4) the diagnosis of aggression syndrome in two clinical domains and evaluation of questionnaires

Exclusion Criteria

The exclusion criteria for mothers and children were as follow: 1) lack of natural intelligence with a criterion of less than 70; 2) use of psychiatric medications due to the possible effect on the psychological syndrome.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
children's aggression 12 weeks aggression scale
Secondary Outcome Measures
NameTimeMethod
level of salivary cortisol 12 weeks ELISA kits
© Copyright 2025. All Rights Reserved by MedPath